Provided by Tiger Trade Technology Pte. Ltd.

Quantum Biopharma Ltd.

2.94
-0.1700-5.47%
Post-market: 2.980.0400+1.36%19:42 EDT
Volume:129.97K
Turnover:393.88K
Market Cap:23.78M
PE:-0.55
High:3.11
Open:3.11
Low:2.94
Close:3.11
52wk High:16.36
52wk Low:2.07
Shares:8.09M
Float Shares:7.65M
Volume Ratio:0.55
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3537
EPS(LYR):-7.9660
ROE:-621.46%
ROA:-51.84%
PB:2.99
PE(LYR):-0.37

Loading ...

Quantum BioPharma Provides Corporate Update

GlobeNewswire
·
Jul 08

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast

TIPRANKS
·
Jul 02

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study

TIPRANKS
·
Jun 30

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy

GlobeNewswire
·
Jun 25

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

TIPRANKS
·
Jun 24

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

GlobeNewswire
·
Jun 23

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for MS Treatment

TIPRANKS
·
Jun 10

Broadcom, Quantinuum, Strategy, Tesla, and More Stocks That Explain Today's Market -- Barrons.com

Dow Jones
·
Jun 06

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets

TIPRANKS
·
Jun 05

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Highlights Lucid-MS and unbuzzd(TM) Growth Opportunities on BioMedWire Podcast

TIPRANKS
·
Jun 03

Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns

GlobeNewswire
·
Jun 02

Quantum BioPharma Provides Corporate Update

GlobeNewswire
·
Jun 02

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 PM

Reuters
·
Jun 02

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study

TIPRANKS
·
May 19

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

GlobeNewswire
·
May 18

Press Release: Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Dow Jones
·
May 07

Quantum BioPharma Provides Corporate Update

GlobeNewswire
·
Apr 28

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

GlobeNewswire
·
Apr 22